Advanz Pharmaceutical - About the company
Advanz Pharmaceutical is an acquired company based in Mississauga (Canada), founded in 1963. It operates as a Manufacturer of specialty generic and off-patent medicines. Advanz Pharmaceutical has raised $13.5M in funding.
Company Details
Advanz Pharmaceutical manufactures specialty generic and off-patent medicines of different dosage forms. The products are of various therapeutic categories including cardiovascular, respiratory, gastrointestinal, antibiotics, antiviral, antifungal, and hematological. and others. In 2018, the company recorded annual revenues of $536M, and a net profit of $1.5B.
- Website
- advanzpharma.com
- Email ID
- *****@advanzpharma.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
1963
Location
Mississauga, Canada
Stage
Acquired
Total Funding
$13.5M in 6 rounds
Latest Funding Round
Investors
Employee Count
458 as on Jul 01, 2024
Exit Details
Acquired by Nordic Capital (Jan 27, 2021)
Legal entities associated with Advanz Pharmaceutical
Advanz Pharmaceutical is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Concordia International Corp. CIN: 1642271 , United States, Active | $5M - $25M (As on Sep 18, 2018) | - | - |
Advanz Pharmaceutical's acquisition details
Advanz Pharmaceutical got acquired by Nordic Capital on Jan 27, 2021 at an acquisition amount of $846M.
Click here to take a look at Advanz Pharmaceutical's acquisition in detail
Sign up to download Advanz Pharmaceutical's company profile
Advanz Pharmaceutical's funding and investors
Advanz Pharmaceutical has raised a total funding of $13.5M over 6 rounds. Its first funding round was on Mar 26, 2007. Its latest funding round was a Post IPO round on Feb 26, 2024 for $*****. 2 investors participated in its latest round. Advanz Pharmaceutical has 2 institutional investors.
Here is the list of recent funding rounds of Advanz Pharmaceutical:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 26, 2024 | 1132632 | Post IPO | 7447784 | 7372488 | 5314481 | 1724357 |
Sep 06, 2018 | 5438248 | Post IPO | 6017429 | 6179212 | 8664729 | 5328924 |
Oct 13, 2016 | 5193408 | Conventional Debt | 2838871 | 4426265 | 1230273 | 9881218 |
View details of Advanz Pharmaceutical's funding rounds and investors
Advanz Pharmaceutical's founders and board of directors
Founder? Claim ProfileAdvanz Pharmaceutical's employee count trend
Advanz Pharmaceutical has 458 employees as of Jul 24. Here is Advanz Pharmaceutical's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Advanz Pharmaceutical's Investments and acquisitions
Advanz Pharmaceutical has acquired 3 companies including Correvio, Pinnacle Biologics and Correvio. Advanz Pharmaceutical has not made any investments as of now.Here is the list of its acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Mar 15, 2020 | Acquisition | 1986 | Vancouver (Canada) | |
Dec 24, 2013 | Acquisition | 2007 | Chicago (United States) | |
Nov 18, 2013 | Acquisition | 1986 | Vancouver (Canada) |
Reports related to Advanz Pharmaceutical
Here is the latest report on Advanz Pharmaceutical's sector:
News related to Advanz Pharmaceutical
Media has covered Advanz Pharmaceutical for a total of 7 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.
•
Alvotech Launches Simponi Biosimilar in Europe with Advanz PharmaGlobeNewswire•Dec 22, 2025•Advanz Pharmaceutical, Alvotech
•
Alvotech and Advanz Pharma Get MHRA Nod for Gobivaz Biosimilar to SimponiGlobeNewswire•Nov 06, 2025•Advanz Pharmaceutical, Alvotech
•
•
EMA Recommends Approval of Alvotech's AVT06, Biosimilar to Eylea (aflibercept)GlobeNewswire•Jun 23, 2025•Alvotech, Advanz Pharmaceutical
•
•
ADVANZ PHARMA’s €1.08 Billion RefinancingGlobal Legal Chronicle•Apr 15, 2025•Advanz Pharmaceutical, Sidley
•
UK regulator accepts biosimilar Xolair application.GlobeNewswire•Mar 26, 2025•Alvotech, Kashiv BioSciences, Advanz Pharmaceutical
•
•
•
EMA accepts Alvotech and Advanz Pharma’s AVT05 MAAPharmaceutical Technology•Nov 05, 2024•Alvotech, Advanz Pharmaceutical
Are you a Founder ?
FAQs about Advanz Pharmaceutical
Explore our recently published companies
- Supernormalpeople - Unfunded company
- Now IT Works - East Hampton based, 2001 founded, Unfunded company
- Willow Creek Wildlife - Fort Pierre based, 2001 founded, Unfunded company
- Husker Cadillac - Lincoln based, 2001 founded, Unfunded company
- TMJ Sleep Therapy Centre - La Mesa based, 2001 founded, Unfunded company
- Quality Subaru - Wallingford based, 2001 founded, Unfunded company
_1549284594127.png?format=webp&height=120&width=120)